Community-Acquired Pneumonia (CAP) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034
Community-Acquired Pneumonia (CAP) Market Outlook Thelansis’s “Community-Acquired Pneumonia (CAP) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Community-Acquired Pneumonia (CAP) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Community-Acquired Pneumonia (CAP) Overview Community-acquired pneumonia (CAP) denotes an acute infection affecting the pulmonary parenchyma in individuals devoid of recent hospitalization within 14 days and not residing in nursing homes or long-term care facilities. The etiology of CAP encompasses two broad categories: Typical agents (e.g., Streptococcus pneumoniae, Haemophilus influenzae, Moraxella c...